Predictors of treatment outcome in patients with paediatric onset multiple sclerosis.

Tine Iskov KoppMorten BlinkenbergThor Ameri ChalmerThor PetersenMads Henrik RavnborgPer Soelberg SørensenMelinda Magyari

Published in: Multiple sclerosis (Houndmills, Basingstoke, England) (2019)

The efficacy of DMT in paediatric onset MS patients is comparable to that seen in adult onset MS patients. Earlier treatment start is associated with a beneficial prognosis in the paediatric cohort.

Keyphrases

multiple sclerosis
end stage renal disease
ejection fraction
emergency department
newly diagnosed
intensive care unit
chronic kidney disease
mass spectrometry
prognostic factors